Drug Reference

Bismuth Biskalcitrate / Metronidazole / Tetracycline

← All medicines

Pediatric caution

Available as

140 MG · Oral Capsule
Multi-ingredient product
Bismuth BiskalcitrateMetronidazoleTetracycline

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Pediatric use

Pediatric caution

Tetracyclines may cause permanent tooth discoloration and affect bone growth when used in children <8 years; weigh against benefit. (Short courses of doxycycline are considered acceptable for some serious infections per AAP/CDC.)

Source: Tetracycline-class labeling; AAP Red Book.

⚑ About half of pediatric medication use is off-label and not described in FDA labels — absence of pediatric information does not mean a medicine is unused or unsafe in children. Confirm with your clinician.

1 marketed product on record (RxNorm)

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.